OLGA and OLGIM Stage System for Gastric Cancer
Launched by SEOUL NATIONAL UNIVERSITY BUNDANG HOSPITAL · Dec 16, 2017
Trial Information
Current as of June 01, 2025
Completed
Keywords
ClinConnect Summary
To validated the OLGA and OLGIM staging system with serum pepsinogen to estimate gastric cancer risk according to Lauren's histologic classification in South Korea, where the incidence rate of GC is high. In addition, the investigators attempted to investigate the interaction among the several risk factors including OLGA or OLGIM staging system for the risk of GC to help establish surveillance strategy.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Control group
- • those who were between 25 and 80 years old and did not have any evidence of gastric cancer and gastric dysplasia, esophageal tumor and MALToma in upper gastrointestinal endoscopy
- • Gastric cancer group
- • Patients diagnosed as gastric cancer in the upper gastrointestinal endoscopy at the time of participating in the study between 25 and 80 years old.
- Exclusion Criteria:
- • history of previous gastrointestinal surgery,
- • any other malignancy
- • cardia cancer
- • who do not perform endoscopic biopsy
- • pathologically proven gastric dysplasia
About Seoul National University Bundang Hospital
Seoul National University Bundang Hospital is a leading academic medical center located in South Korea, renowned for its commitment to innovative research and excellence in patient care. As a sponsor of clinical trials, the hospital leverages its extensive expertise in various medical fields, employing cutting-edge technologies and methodologies to advance healthcare solutions. With a multidisciplinary team of skilled researchers and clinicians, the hospital aims to enhance clinical outcomes through rigorous investigation and collaboration, contributing significantly to the global medical community and improving patient lives.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Seongnam Si, Gyeonggi Do, Korea, Republic Of
Seongnam Si, Gyeonggi Do, Korea, Republic Of
Patients applied
Trial Officials
Officials Officials, Officials
Principal Investigator
Seoul National University Bundang Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials